LabCompass

Nathan Denlinger

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2007Rising activity
CAR-T cell therapy researchLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders researchHematopoietic Stem Cell TransplantationViral Infectious Diseases and Gene Expression in Insects

Publications

85

Citations

894

Est. group size

~42

Recurring co-author estimate

Active years

20

Publishing since 2007

Research summary
AI-generated

Nathan Denlinger's research focuses on treatments for blood cancers, particularly lymphoma and leukemia, with a strong emphasis on CAR-T cell therapy, a treatment that reprograms a patient's own immune cells to attack cancer. His recent work examines the real-world effectiveness, safety, and side effects of these therapies, as well as how factors like social determinants of health and blood biomarkers relate to treatment outcomes.

CAR-T cell therapyLymphoma treatmentLeukemia immunotherapyHematopoietic stem cell transplantationCancer treatment side effects

Publication output has grown substantially over the last decade, rising from just a few papers per year in 2017-2019 to a much higher and sustained rate of 12-18 papers annually since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 12.4/year recently
2017: 3 publications172018: 3 publications182019: 2 publications192020: 5 publications202021: 5 publications212022: 10 publications222023: 6 publications232024: 18 publications18242025: 16 publications252026: 12 publications26
Recent publications
Publishes in
  • Blood×21
  • Transplantation and Cellular Therapy×18
  • Blood Advances×5
  • Clinical Lymphoma Myeloma & Leukemia×5
  • Journal of Clinical Oncology×5
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile